*as proven in beta
Reach 1.6M+ verified and opted-in healthcare providers and 300M+ patients in a HIPAA-compliant way.
Access premium, brand-safe endemic and non-endemic inventory from thousands of media partners across every device.
Directly integrated with clinical data in a privacy-safe and HIPAA-compliant way.
DeepIntent was conceived by former Memorial Sloan Kettering data scientists with the core belief that marketing technology can measurably improve the lives of patients. Built purposefully for healthcare marketers, DeepIntent’s market-leading innovations empower healthcare marketers to reach 1.6M+ verified and opted-in healthcare providers and 300M+ patients in a HIPAA-compliant way. In one single platform, marketers can effectively plan and scale provider and patient campaigns with real-world clinical data; activate campaigns immediately across every channel and device within curated, premium, brand safe inventory from thousands of endemic and non-endemic media partners; and measure and optimize campaigns toward business outcomes in real time with patented technology.
The recent launch of DeepIntent Outcomes, a patented script optimization engine, makes DeepIntent’s the only DSP able to optimize live campaigns based on clinical data toward audience quality and script performance. Machine learning algorithms consider each aspect of a campaign before selecting the optimal creative, audience, frequency, inventory, geography, and more to serve ads. As a result, DeepIntent Outcomes has been proven in beta to increase script lift by up to 35% and on average, improves audience quality by 50%+.
Serving seven of the top pharmaceutical companies and all major advertising agency holding groups, DeepIntent has won two PM360 Innovator Awards as well as the 2020 Digiday Technology Award in the Best Buy-Side Programmatic Platform category.